Are kidneys from donors who had dialysis more likely to result in adverse outcomes for transplant recipients? Researchers examined how cardiovascular health status differs between men and women with kidney failure. Ardelyx is suing the HHS and CMS over their addition of oral phosphate-lowering drugs to a bundled payment system. DaVita has agreed to pay $34,487,390 to resolve allegations that it paid illegal kickbacks. Kidney care services provider Fresenius Medical Care has entered into five wind and solar power purchase agreements. The co-directors of Stanford's NephroNICU Program spoke about their unique program. Dietitian Jessica Strawn shared her ideas on how to educate patients about changing from heart catheters to AVF for dialysis. It is essential for nephrology practices and dialysis centers to have backup methods for processing claims. The ETC payment model gave lower performance scores to dialysis facilities serving more patients at higher social risk. More than two-thirds of young patients receiving CKRT experienced major adverse kidney events 90 days after CKRT initiation. Accreditation Commission for Health Care, Inc. (ACHC) will offer a new Long-Term Care Dialysis Certification. The FDA granted 510(k) clearance to TabloCart with prefiltration, an accessory for the Tablo Hemodialysis System. DaVita honored 54 of its nephrology nurses with the DAISY Award for Extraordinary Nurses during National Nurses Week. Higher dialysate sodium preserves blood volume and hemodynamic stability but reduces sodium removal. With four acquisitions from Fresneius Medical Care, DaVita will become the largest dialysis provider in Latin America. Outset Medical and US Renal Care have partnered to advance home dialysis with the Outset Tablo Hemodialysis System. A bill to improve access to care and outcomes for some dialysis patients was introduced in the House of Representatives. Older dialysis-dependent patients are at high risk of low bone mass associated with primary osteoporosis, CKD-MBD, or both. Eurofins Scientific has acquired Ascend Clinical, the largest independent laboratory for kidney dialysis testing in the US. Researchers investigated COVID-19 diagnoses and related hospitalization or death in dialysis patients.